Cases 71 - 80 of 416
RIGEL PHARMACEUTICALS, INC. v. ANNORA PHARMA PRIVATE LTD. et al
as 3:2022cv04732
Plaintiff:
RIGEL PHARMACEUTICALS, INC.
Defendant:
ANNORA PHARMA PRIVATE LTD., HETERO LABS LTD. and HETERO USA, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
GARNER v. HETERO DRUGS, LTD. et al
as 1:2022cv04674
Plaintiff:
NATALIE GARNER
Defendant:
HETERO DRUGS LTD., HETERO LABS LTD., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
RODDEY v. HETERO LABS, LTD. et al
as 1:2022cv04540
Plaintiff:
INA MARIE RODDEY
Defendant:
HETERO LABS, LTD., JOHN DOE, CAMBER PHARMACEUTICALS INC. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Aragon Pharmaceuticals, Inc. et al v. Hetero Labs Limited Unit V et al
as 1:2022cv00696
Plaintiff:
Aragon Pharmaceuticals, Inc., Janssen Biotech, Inc., The Regents of the University of California and others
Defendant:
Hetero Labs Limited Unit V and Hetero USA, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
THE ESTATE OF CONNIE KEEP v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv02461
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Plaintiff:
CHARLES KEEP and THE ESTATE OF CONNIE KEEP
Defendant:
AUROBINDO PHARMA, LTD., TEVA PHARMACEUTICAL INDUSTRIES, LTD., ACTAVIS PHARMA INC. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
BASS v. HETERO DRUGS, LTD. et al
as 1:2022cv04151
Plaintiff:
LARRY W. BASS
Defendant:
HETERO DRUGS, LTD., HETERO LABS, LTD., ZHEJIANG HUAHAI PHARMACEUTICAL CO. LTD. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
KING-BRANCH v. ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. et al
as 1:2022cv03856
Plaintiff:
LETITIA KING-BRANCH
Defendant:
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD., HUAHAI U.S. INC., SOLCO HEALTHCARE U.S., LLC and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
QUARLES v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv03385
Plaintiff:
WILLIE QUARLES
Defendant:
AUROBINDO PHARMA, LTD., HETERO DRUGS, LTD., HETERO LABS, LTD. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Merck Sharp & Dohme Corp. et al v. Hetero Labs Limited et al
as 1:2022cv00378
Plaintiff:
Merck Sharp & Dohme Corp., MSD International Business GmbH, MSD International GmbH and others
Defendant:
Hetero Labs Limited, Hetero Labs Limited Unit-V and Hetero USA Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
PARKER v. HETERO DRUGS, LTD. et al
as 1:2022cv02419
Plaintiff:
ROBERT GLENN PARKER
Defendant:
HETERO DRUGS, LTD., HETERO LABS, LTD., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
